What is Dyne Therapeutics, Inc.'s change in other assets?

Dyne Therapeutics, Inc. (DYN) reported change in other assets of -$28K in Q1 2026.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Dyne Therapeutics, Inc. DYN Change in Other Assets

Change in Other Assets at other companies

Ionis PharmaceuticalsIONS

$7.39M-40.2%

Arrowhead ResearchARWR

$13.18M+2,127%

Edgewise Therapeutics, Inc.EWTX

-$3.05M-306%

PTC TherapeuticsPTCT

-$1.18M-107%

Scholar RockSRRK

$37K+142%

Catalyst PharmaceuticalCPRX

-$2.45M+65.1%

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s change in other assets?: Dyne Therapeutics, Inc. (DYN) reported change in other assets of -$28K in Q1 2026.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.